Clinical Trial Update: A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS Related Complex (ARC) [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the combination of zalcititabine (dideoxycytidine) and zidovudine for AIDS or AIDS-related complex; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Aids-related Complex
• Human Immunodeficiency Virus Infection

Drugs mentioned

• Hivid (zalcitabine)
• RETROVIR (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED